Navigation Links
Mitchel Sayare, Ph.D. to Succeed John Pappajohn as Chairman of the Company's Board of Directors
Date:7/15/2011

ANNAPOLIS, Md., July 15, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company's Board of Directors has elected Mitchel Sayare, Ph.D. to succeed John Pappajohn as Chairman of the Board. Mr. Pappajohn stepped down from the PharmAthene Board effective immediately.

Dr. Sayare has been a member of PharmAthene's Board of Directors since April 2010, and most recently served from 1985 until 2010 as Chairman and Chief Executive Officer of ImmunoGen, a publicly traded biotechnology company engaged in the research and development of antibody-based cancer therapeutics.  During his long and successful tenure with ImmunoGen, Dr. Sayare was responsible for leading an IPO and raising over $400 million in venture capital and public equity financing for the company.  During this time, Dr. Sayare also served as President of the 95%-owned ImmunoGen subsidiary, Apoptosis Technology, where he was responsible for managing operations for the organization.

Prior to joining ImmunoGen, Dr. Sayare served as Vice President, Development at Xenogen, Inc., a biotechnology company specializing in monoclonal antibody-based diagnostic systems for cancer.  In this role he oversaw all research and development, corporate development, and investor relations responsibilities for the company.  Dr. Sayare earned his Ph.D. in biochemistry from the Temple University School of Medicine and his undergraduate degree from Ursinus College.

"Mitch has been an invaluable asset to our Company and we are delighted he has agreed to assume the Chairmanship of the Board of Directors," remarked Eric I. Richman, President and Chief Executive Officer.   "As a former Director and Treasurer of the Biotechnology Industry Organization (BIO), his extensive exper
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
2. Georgia Power to Delay Plant Mitchell Conversion to Biomass
3. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
4. Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner
5. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
6. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
7. Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
8. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
9. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
10. Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors
11. Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Protocol Networks brings independent technology consulting to the ... consultants, Protocol Networks has recently announced its expansion into ... his company has attracted several clients in The Constitution ... as others. With the success of these engagements, Rogers ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently ... Supplements Pre-Conference seminar on probiotics in San Diego, CA. ... education conference for health care professionals. This year’s pre-conference seminar ... probiotics in health. Dr. Leyer spoke about the emerging topics ...
(Date:1/22/2015)... BRUNSWICK , Nueva Jersey , 22 de ... Award for Biomedical Research abre hoy su llamada a ... personas cuya investigación científica ha hecho, o tiene el ... la salud humana. Las nominaciones se aceptarán hasta el ...
(Date:1/22/2015)... 2015  Derma Sciences, Inc. (Nasdaq: DSCI ... wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic ... to the Premier, Inc. Regenerative Skin Grafting contract ... AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to ...
Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... Calif., March 6 Finesse Solutions, LLC, Santa Clara, ... life sciences process applications, announced the technical demonstration of ... at Interphex in New York on March 17, 2009.The ... consisting of a disposable sheath, an optical reader, and ...
... SEATTLE, March 6 Cell Therapeutics, Inc. (CTI) (Nasdaq ... a letter from The NASDAQ Stock Market indicating that ... the listing of the Company,s common stock on The ... or before April 6, 2009, the Company demonstrate compliance ...
... 6 Irvine Scientific, a leading medical device/biopharmaceutical company ... the addition of IS CHO-CD XP(TM) Culture System to ... Culture System is a set of chemically-defined*, serum-free, and ... deliver robust cell growth and production for recombinant CHO ...
Cached Biology Technology:Finesse Demonstrates TruFluor(TM) pH, a Single-Use Optical pH Sensor and Transmitter 2Cell Therapeutics Announces Receipt of NASDAQ Listing Update 2Cell Therapeutics Announces Receipt of NASDAQ Listing Update 3Irvine Scientific Launches IS CHO-CD XP(TM) 2
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, today announced ... genetic ancestry of individuals from across the United ... than four hundred years ago, the United States ... from different continents. This study illuminates how American history and ...
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... systems. Multimodal biometric systems utilize more than one characteristic ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... The most robust statistical examination to date of our species, ... all living humans -- confirms that she lived about 200,000 ... side-by-side comparison of 10 human genetic models that each aim ... of assumptions about the way humans migrated, expanded and spread ...
... lead to a brand new class of drugs to treat ... back pain without numbing the whole body. The ... (BBSRC) and working at UCL (University College London), have shown ... are regulated by molecules inside cells called small RNAs. This ...
... the best of times, but plants have an extra difficulty. If ... and reproduce, you will want your flowerstalks to be long. That ... But if your stalk is too long, you,ll stand out to ... used to be thought that carnivorous plants like Sundews had the ...
Cached Biology News:Mother of all humans lived 200,000 years ago 2Mother of all humans lived 200,000 years ago 3Scientists uncover Achilles heel of chronic inflammatory pain 2Sundews just want to be loved 2
... difficult to achieve in many bacterial strains ... more restriction and modification (R-M) systems that ... "foreign". TypeOne™ Restriction Inhibitor provides a powerful ... strains with type I R-M systems. ...
... loxP-cm-loxP cassette is designed to ... The prokaryotic promoter gb2 driving ... a slightly modified version of the ... efficiency than the generally used Tn5 ...
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
... for stabilizing 1.5mg of purified RNA samples., ... the stabilization of aqueous RNA samples that ... as guanidine, phenol/chloroform, silica, oligo dT etc ... contain all the necessary components for the ...
Biology Products: